Copyright Reports & Markets. All rights reserved.

Global Sodium Hyaluronate (HA) for Ophthalmology Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Biological Extraction
    • 1.3.3 Ferment
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Eye Drops
    • 1.4.3 Eye Surgery
    • 1.4.4 Others
  • 1.5 Global Sodium Hyaluronate (HA) for Ophthalmology Market Size & Forecast
    • 1.5.1 Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity (2020-2031)
    • 1.5.3 Global Sodium Hyaluronate (HA) for Ophthalmology Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Bloomage Biotech
    • 2.1.1 Bloomage Biotech Details
    • 2.1.2 Bloomage Biotech Major Business
    • 2.1.3 Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.1.4 Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Bloomage Biotech Recent Developments/Updates
  • 2.2 Shandong Focuschem Biotech
    • 2.2.1 Shandong Focuschem Biotech Details
    • 2.2.2 Shandong Focuschem Biotech Major Business
    • 2.2.3 Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.2.4 Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Shandong Focuschem Biotech Recent Developments/Updates
  • 2.3 Fufeng Group
    • 2.3.1 Fufeng Group Details
    • 2.3.2 Fufeng Group Major Business
    • 2.3.3 Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.3.4 Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Fufeng Group Recent Developments/Updates
  • 2.4 Shandong Awa Biopharm
    • 2.4.1 Shandong Awa Biopharm Details
    • 2.4.2 Shandong Awa Biopharm Major Business
    • 2.4.3 Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.4.4 Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Shandong Awa Biopharm Recent Developments/Updates
  • 2.5 China Eastar Group
    • 2.5.1 China Eastar Group Details
    • 2.5.2 China Eastar Group Major Business
    • 2.5.3 China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.5.4 China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 China Eastar Group Recent Developments/Updates
  • 2.6 Kewpie
    • 2.6.1 Kewpie Details
    • 2.6.2 Kewpie Major Business
    • 2.6.3 Kewpie Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.6.4 Kewpie Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Kewpie Recent Developments/Updates
  • 2.7 Contipro
    • 2.7.1 Contipro Details
    • 2.7.2 Contipro Major Business
    • 2.7.3 Contipro Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.7.4 Contipro Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Contipro Recent Developments/Updates
  • 2.8 Seikagaku
    • 2.8.1 Seikagaku Details
    • 2.8.2 Seikagaku Major Business
    • 2.8.3 Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.8.4 Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Seikagaku Recent Developments/Updates
  • 2.9 HTL Biotechnology
    • 2.9.1 HTL Biotechnology Details
    • 2.9.2 HTL Biotechnology Major Business
    • 2.9.3 HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.9.4 HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 HTL Biotechnology Recent Developments/Updates
  • 2.10 Fidia Farmaceutici
    • 2.10.1 Fidia Farmaceutici Details
    • 2.10.2 Fidia Farmaceutici Major Business
    • 2.10.3 Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.10.4 Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Fidia Farmaceutici Recent Developments/Updates
  • 2.11 LG Life Sciences
    • 2.11.1 LG Life Sciences Details
    • 2.11.2 LG Life Sciences Major Business
    • 2.11.3 LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.11.4 LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 LG Life Sciences Recent Developments/Updates
  • 2.12 Haohai Biological Technology
    • 2.12.1 Haohai Biological Technology Details
    • 2.12.2 Haohai Biological Technology Major Business
    • 2.12.3 Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.12.4 Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Haohai Biological Technology Recent Developments/Updates
  • 2.13 Elravie (Humedix)
    • 2.13.1 Elravie (Humedix) Details
    • 2.13.2 Elravie (Humedix) Major Business
    • 2.13.3 Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.13.4 Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Elravie (Humedix) Recent Developments/Updates
  • 2.14 SciVision Biotech
    • 2.14.1 SciVision Biotech Details
    • 2.14.2 SciVision Biotech Major Business
    • 2.14.3 SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Product and Services
    • 2.14.4 SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 SciVision Biotech Recent Developments/Updates

3 Competitive Environment: Sodium Hyaluronate (HA) for Ophthalmology by Manufacturer

  • 3.1 Global Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Sodium Hyaluronate (HA) for Ophthalmology Revenue by Manufacturer (2020-2025)
  • 3.3 Global Sodium Hyaluronate (HA) for Ophthalmology Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Sodium Hyaluronate (HA) for Ophthalmology by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Sodium Hyaluronate (HA) for Ophthalmology Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Sodium Hyaluronate (HA) for Ophthalmology Manufacturer Market Share in 2024
  • 3.5 Sodium Hyaluronate (HA) for Ophthalmology Market: Overall Company Footprint Analysis
    • 3.5.1 Sodium Hyaluronate (HA) for Ophthalmology Market: Region Footprint
    • 3.5.2 Sodium Hyaluronate (HA) for Ophthalmology Market: Company Product Type Footprint
    • 3.5.3 Sodium Hyaluronate (HA) for Ophthalmology Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sodium Hyaluronate (HA) for Ophthalmology Market Size by Region
    • 4.1.1 Global Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Region (2020-2031)
    • 4.1.3 Global Sodium Hyaluronate (HA) for Ophthalmology Average Price by Region (2020-2031)
  • 4.2 North America Sodium Hyaluronate (HA) for Ophthalmology Consumption Value (2020-2031)
  • 4.3 Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption Value (2020-2031)
  • 4.5 South America Sodium Hyaluronate (HA) for Ophthalmology Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Type (2020-2031)
  • 5.2 Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Type (2020-2031)
  • 5.3 Global Sodium Hyaluronate (HA) for Ophthalmology Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Application (2020-2031)
  • 6.2 Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Application (2020-2031)
  • 6.3 Global Sodium Hyaluronate (HA) for Ophthalmology Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Type (2020-2031)
  • 7.2 North America Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Application (2020-2031)
  • 7.3 North America Sodium Hyaluronate (HA) for Ophthalmology Market Size by Country
    • 7.3.1 North America Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Type (2020-2031)
  • 8.2 Europe Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Application (2020-2031)
  • 8.3 Europe Sodium Hyaluronate (HA) for Ophthalmology Market Size by Country
    • 8.3.1 Europe Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Sodium Hyaluronate (HA) for Ophthalmology Market Size by Region
    • 9.3.1 Asia-Pacific Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Type (2020-2031)
  • 10.2 South America Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Application (2020-2031)
  • 10.3 South America Sodium Hyaluronate (HA) for Ophthalmology Market Size by Country
    • 10.3.1 South America Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Market Size by Country
    • 11.3.1 Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Sodium Hyaluronate (HA) for Ophthalmology Market Drivers
  • 12.2 Sodium Hyaluronate (HA) for Ophthalmology Market Restraints
  • 12.3 Sodium Hyaluronate (HA) for Ophthalmology Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sodium Hyaluronate (HA) for Ophthalmology and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sodium Hyaluronate (HA) for Ophthalmology
  • 13.3 Sodium Hyaluronate (HA) for Ophthalmology Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sodium Hyaluronate (HA) for Ophthalmology Typical Distributors
  • 14.3 Sodium Hyaluronate (HA) for Ophthalmology Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Sodium Hyaluronate (HA) for Ophthalmology market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Sodium hyalurate (SH) is a macromolecular mucopolysaccharide, which exists in the tissues of various animals, but it is mostly in the combs and human umbilical cord and placenta tissues.
    Currently, the Sodium Hyaluronate (HA) for Ophthalmology is mainly extracted from cockscomb or prepared by fermentation.
    This report is a detailed and comprehensive analysis for global Sodium Hyaluronate (HA) for Ophthalmology market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Sodium Hyaluronate (HA) for Ophthalmology market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Sodium Hyaluronate (HA) for Ophthalmology market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Sodium Hyaluronate (HA) for Ophthalmology market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Sodium Hyaluronate (HA) for Ophthalmology market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sodium Hyaluronate (HA) for Ophthalmology
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sodium Hyaluronate (HA) for Ophthalmology market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bloomage Biotech, Shandong Focuschem Biotech, Fufeng Group, Shandong Awa Biopharm, China Eastar Group, Kewpie, Contipro, Seikagaku, HTL Biotechnology, Fidia Farmaceutici, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Sodium Hyaluronate (HA) for Ophthalmology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Biological Extraction
    Ferment
    Market segment by Application
    Eye Drops
    Eye Surgery
    Others
    Major players covered
    Bloomage Biotech
    Shandong Focuschem Biotech
    Fufeng Group
    Shandong Awa Biopharm
    China Eastar Group
    Kewpie
    Contipro
    Seikagaku
    HTL Biotechnology
    Fidia Farmaceutici
    LG Life Sciences
    Haohai Biological Technology
    Elravie (Humedix)
    SciVision Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Sodium Hyaluronate (HA) for Ophthalmology product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Sodium Hyaluronate (HA) for Ophthalmology, with price, sales quantity, revenue, and global market share of Sodium Hyaluronate (HA) for Ophthalmology from 2020 to 2025.
    Chapter 3, the Sodium Hyaluronate (HA) for Ophthalmology competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Sodium Hyaluronate (HA) for Ophthalmology breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sodium Hyaluronate (HA) for Ophthalmology market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Sodium Hyaluronate (HA) for Ophthalmology.
    Chapter 14 and 15, to describe Sodium Hyaluronate (HA) for Ophthalmology sales channel, distributors, customers, research findings and conclusion.

    Buy now